{"id":"NCT02462083","sponsor":"Bausch Health Americas, Inc.","briefTitle":"Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis","officialTitle":"A Phase 3, Multicenter, Open Label Study to Evaluate the Long-Term Safety of IDP-118 Lotion in the Treatment of Plaque Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-08-11","primaryCompletion":"2017-01-31","completion":"2017-04-24","firstPosted":"2015-06-03","resultsPosted":"2020-01-27","lastUpdate":"2020-01-27"},"enrollment":555,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Plaque Psoriasis"],"interventions":[{"type":"DRUG","name":"IDP-118 Lotion","otherNames":[]}],"arms":[{"label":"IDP-118 Lotion","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to evaluate the long-term safety of IDP-118 lotion.","primaryOutcome":{"measure":"Percentage of Participants Who Experienced Grade 3 Local Skin Reactions","timeFrame":"Baseline up to Week 52","effectByArm":[{"arm":"IDP-118 Lotion","deltaMin":22.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":46,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":18,"n":550},"commonTop":["Application site dermatitis","Application site pruritus","Application site pain","Nasopharyngitis"]}}